Effect of cytochrome P450 2C19*17 allelic variant on cardiovascular and cerebrovascular outcomes in clopidogrel-treated patients: A systematic review and meta-analysis
Background: We aimed to evaluate the associations of gain-of-function allele of CYP2C19* 17 and risk of clinical events in clopidogrel-treated patients with cardiovascular and cerebrovascular diseases (CCVDs). Materials and Methods: Literature search was conducted in PubMed, EMBASE, and Cochrane Lib...
Main Authors: | Bo Huang, De-Jun Cui, Ying Ren, Bin Han, Da-Ping Yang, Xun Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2017;volume=22;issue=1;spage=109;epage=109;aulast=Huang |
Similar Items
-
Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
by: Luhai Yu, et al.
Published: (2021-08-01) -
Clopidogrel Resistance in Stroke Cases
by: Nihan Çarçak, et al.
Published: (2019-11-01) -
Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients
by: Renske H. Olie, et al.
Published: (2021-09-01) -
Elevated levels of adiponectin associated with major adverse cardiovascular and cerebrovascular events and mortality risk in ischemic stroke
by: Wen-Jun Tu, et al.
Published: (2020-08-01) -
Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01)